Convertible Note - Artax Biopharma
Investment Firm
Overview
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Announced Date
Aug 06, 2024
Closed on Date
Aug 06, 2024
Funding Type
Convertible Note
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Artax Biopharma raised $8000000 on 2024-08-06 in Convertible Note
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 06, 2024 |  Convertible Note - Artax Biopharma | 5 | - | 8.0M |
| Sep 22, 2015 | Series B - Artax Biopharma | 2 | - | 10.0M |
| Oct 12, 2014 | Series A - Artax Biopharma | 1 | - | 2.0M |
| Sep 26, 2013 | Venture Round - Artax Biopharma | - | 1.3M |
Recent Activity
There is no recent news or activity for this profile.